Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7194 p521-527
20 April 2002


News summary

News in brief


Consultation starts on supplementary prescribing by pharmacists and nurses Pharmacists could be writing prescriptions next year if proposals published this week are implemented...[more]

Company chemists seek full-time chief executive The Company Chemists Association, which represents the largest pharmacy multiples, is to appoint its first full-time chief executive who will be based at new offices in Milton Keynes...[more]

Chancellor promises over 40 per cent more for the NHS in the next five years The Chancellor of the Exchequer (Gordon Brown) has promised to invest 43 per cent more money in the National Health Service over the next five years...[more]

Pharmacists warn medical staff about their prescribing errors Junior doctors should be trained in the principles of drug dosing and medical staff should promote a working culture that recognises the importance of prescription writing, say pharmacists in this week's issue of The Lancet...[more]

"Pharmacists are unsung heroes" Health Minister Hazel Blears described hospital pharmacists as unsung heroes and heroines for their work on medicines management...[more]

A social insurance scheme for Britain? A new social insurance scheme for funding Britain's Health Service was proposed last week in a report from the Adam Smith Institute. However the proposal will face opposition from the Government, which believes that sustained investment funded from taxation and continued reform is the way forward...[more]

Generic omeprazole launched Generic versions of omeprazole were launched in the United Kingdom this week...[more]

Pfizer seeks to lift Viagra restrictions Pfizer has launched a High Court bid to lift the restrictions placed on the supply of sildenafil (Viagra)...[more]

Contribution to balance of trade by pharmaceuticals still increasing The United Kingdom's balance of trade in pharmaceuticals increased by 21 per cent during 2001...[more]

NICE endorses costly inhaler devices for children if asthma better controlled Press-and-breathe metered dose inhalers (MDIs) with a suitable spacer device should be used first-line to deliver inhaled corticosteroids for routine treatment of chronic asthma in children aged 5–15 years, says the National Institute for Clinical Excellence...[more]

Levetiracetam is an effective add-on epilepsy treatment LEVETIRACETAM (Keppra) is an effective adjunctive treatment for adults with partial epilepsy that is not controlled with standard antiepileptic drugs, according to the Drug and Therapeutics Bulletin...[more]

Zyban safety update Following guidance on the use of smoking cessation therapies by the National Institute for Clinical Excellence last week, the Medicines Control Agency has issued a safety update for bupropion (Zyban)...[more]

Psychological interventions not useful in epilepsy No reliable evidence supports the use of psychological interventions in treating epilepsy, researchers say...[more]

Green tea protects against Parkinson's Polyphenols present in green tea might have a protective effect in Parkinson's disease, say researchers...[more]

Malaria patients — in or out? Patients with imported malaria can be treated safely as outpatients, provided that criteria for severity are considered, say Swiss researchers...[more]

Medicines management guide launched A new guide to medicines management has been launched this week. "Modernising medicines management: a guide to achieving benefits for patients, professionals and the NHS" has been produced by the National Prescribing Centre and the National Primary Care Research and Development Centre...[more]

Patients expected to pay for AAH medicines management services AAH Pharmaceuticals has launched a new medicines management programme for selected community pharmacies...[more]

PSNC starts talks on contract for 2003 The Pharmaceutical Services Negotiating Committee has started a series of meetings with the Department of Health on the new contract for community pharmacy in England and Wales...[more]

Dentists' retention fee rises by 260pc Dentists will have to pay an annual retention fee of £350 next year, the General Dental Council has decided...[more]

Reminyl of benefit in vascular dementia Patients with dementia and cerebrovascular disease benefit from treatment with galantamine (Reminyl), say researchers...[more]

Nicorandil reduces coronary events in stable angina patients The potasssium-channel activator nicorandil (Ikorel) has some impact on the incidence of major coronary events in patients with stable angina, report researchers...[more]

MeReC Extra on heart failure therapy The benefits of using an angiotensin converting enzyme (ACE) inhibitor and aspirin in patients with heart failure and coronary heart disease outweigh the consequences of their possible interaction, concludes the latest issue of MeReC Extra...[more]

Disease mongering is a marketing ploy Health professionals are among those who should move away from using corporately funded information about medical conditions...[more]

Irish deregulation petition attracts 300,000 signatures More than 300,000 people in the Irish Republic are publicly backing pharmacists in their opposition to the government's decision to deregulate the sector...[more]

Pharmacists urged to publish work Hospital pharmacists have been urged to publish the good work they are accomplishing and thereby add to the evidence showing the usefulness of the hospital pharmacy service...[more]

Smallpox vaccine supply contract awarded A contract to supply the National Health Service with smallpox vaccine was awarded on 12 April...[more]


NEWS IN BRIEF


Boots The Chemists is holding its third annual series of clinical governance road shows across Britain. This year, the focus is on risk awareness and risk management. All Boots pharmacists have been invited and the 22 road shows will be completed by the end of this month.
www.wellbeing.com


  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal